CN108567888A - 一种百苓膏及其制备方法 - Google Patents
一种百苓膏及其制备方法 Download PDFInfo
- Publication number
- CN108567888A CN108567888A CN201710941477.3A CN201710941477A CN108567888A CN 108567888 A CN108567888 A CN 108567888A CN 201710941477 A CN201710941477 A CN 201710941477A CN 108567888 A CN108567888 A CN 108567888A
- Authority
- CN
- China
- Prior art keywords
- parts
- hundred
- cream
- siberian cocklebur
- siberian
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001251949 Xanthium sibiricum Species 0.000 title claims abstract description 45
- 239000006071 cream Substances 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 241000234435 Lilium Species 0.000 claims abstract description 17
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 17
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 17
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 17
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 16
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 15
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 15
- 244000197580 Poria cocos Species 0.000 claims abstract description 14
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 14
- 244000126014 Valeriana officinalis Species 0.000 claims abstract description 14
- 235000013832 Valeriana officinalis Nutrition 0.000 claims abstract description 14
- 235000016788 valerian Nutrition 0.000 claims abstract description 14
- 241000218231 Moraceae Species 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 238000000605 extraction Methods 0.000 claims abstract description 5
- 235000000346 sugar Nutrition 0.000 claims description 13
- 239000000654 additive Substances 0.000 claims description 11
- 230000000996 additive effect Effects 0.000 claims description 11
- 239000012141 concentrate Substances 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 235000009508 confectionery Nutrition 0.000 claims description 7
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 239000001814 pectin Substances 0.000 claims description 6
- 229920001277 pectin Polymers 0.000 claims description 6
- 235000010987 pectin Nutrition 0.000 claims description 6
- 239000011435 rock Substances 0.000 claims description 6
- 241000905535 Empyreuma Species 0.000 claims description 3
- 241000238370 Sepia Species 0.000 claims description 3
- 230000001476 alcoholic effect Effects 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000003814 drug Substances 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 12
- 229940079593 drug Drugs 0.000 abstract description 6
- 239000000203 mixture Substances 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 230000003860 sleep quality Effects 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 230000001256 tonic effect Effects 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 12
- 206010022437 insomnia Diseases 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 230000036578 sleeping time Effects 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 240000000249 Morus alba Species 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 208000019116 sleep disease Diseases 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000022925 sleep disturbance Diseases 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229960002708 antigout preparations Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 208000024335 physical disease Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明一种百苓膏及其制备方法,属于中药技术领域;由以下重量份配比的原料制备而成:百合1‑3份,茯苓3‑5份,莲子4‑5份,桑葚1‑3份,龙眼肉4‑5份,缬草1‑3份;本发明改善睡眠的百苓膏,配方配伍合理,制备方法简单,充分考虑到组合物中各种药物成分的充分提取,可以使原料药充分发挥治疗作用和滋补作用,能够有效改善睡眠质量,服用方便,安全无毒副作用。
Description
技术领域
本发明一种百苓膏及其制备方法,属于中药技术领域。
背景技术
失眠即睡眠失常。表现为入睡困难,断断续续不连贯,而过早地醒来,醒后不能再继续睡,睡眠深度或频度过短(浅睡性失眠)、早醒及睡眠时间不足或质量差。失眠是由于情志、饮食内伤,或病后及年迈,禀赋不足,心虚胆怯等病因,引起心神失养或心神不安,从而导致经常不能获得正常睡眠为特征的一类病症。随着人们生活节奏的加快,以及社会、家庭等方面的压力,现在越来越多的人们患有失眠、头晕、头疼、健忘、乏力等症状,给患者带来了巨大的身体和精神上的痛苦。
对于失眠的治疗,西药治疗效果快,但是毒副作用大,容易形成依赖。
发明内容
本发明克服现有技术的不足,所要解决的技术问题是提供一种具有改善睡眠功能的百苓膏及其制备方法。
为解决上述技术问题,本发明所采用的技术方案为:一种百苓膏,由以下重量份配比的原料制备而成:百合1-3份,茯苓3-5份,莲子4-5份,桑葚1-3份,龙眼肉4-5份,缬草1-3份。
优选的,其由以下重量份配比的原料制备而成:百合2份,茯苓4份,莲子3份,桑葚2份,龙眼肉3份,缬草2份。
本发明中各原料的药性如下:
百合:含有蛋白质、脂肪、还原糖、淀粉,以及钙、磷、铁、克维生素B、维生素C、秋水仙碱等多种活性成分。在我国百合药食两用已有上千年的历史,适宜体虚肺弱,神经衰弱,睡眠不宁者。科学地食用百合,有降糖、抗肿瘤、抗痛风、改善睡眠、提高免疫力等作用。
茯苓:被称为“四时神药”,因为其功效十分广泛,将它与其他药物配伍,不论寒、温、风、湿诸疾,都能发挥其独特的功效。其味甘、淡、性平,归心、脾、肾经,入药具有利水渗湿、健脾、宁心之功用。
莲子:不仅含有丰富的蛋白质、碳水化合物、维生素和Ca、Fe、Zn等微量元素,还含有水溶性多糖、黄酮类物质、生物碱和超氧化物歧化酶等成分。《神农本草经》医药典籍中记载莲子入脾、肾、心经,具有清心醒脾、补胃止泻、安心养神明目、止泻固精、滋补元气等功效。现代药理研究也证实莲子有镇静、强心、抗衰老、提高免疫力、降血糖等多种作用。
桑葚:营养价值极高,含有丰富的活性蛋白质、维生素、氨基酸、胡萝卜素、矿物质等成分。中医研究认为桑葚味甘酸、性寒,入肝、肾经,既能补益肝肾,又能凉血退热;还有生津润燥、乌发明目、滋阴补血、解毒养颜等功效,常用于阴血不足、目暗昏花、津伤口渴、肠燥便秘等证。
龙眼肉:味甘、性温,归心、脾经。具有补益心脾、养血安神等功效,适用于思虑过度、气血亏虚、劳伤心脾、神经衰弱、惊悸怔忡、失眠健忘等病症。
缬草:化学成分主要有挥发油、环稀酸薛、木脂素、生物碱、黄酮等,传统医学认为缬草味辛、甘,性温,归心、肝经,具有理气、养心安神、活血止痛的功效。现代医学研究表明缬草醇提取物可以增强睡眠时间,有扩张冠脉血管,改善心肌缺血,降低心肌耗氧量和抗心律失常的作用。
一种制备百苓膏的方法,包括以下步骤:
(1)取重量份配比的百合、茯苓、莲子、桑葚、龙眼肉加水煎煮,过滤,取滤液备用;
(2)取重量份配比的缬草用酒精度为35%粮酒回流提取得提取液;
(3)将步骤(1)所得的滤液和步骤(2)所得提取液合并后浓缩,浓缩至80℃时相对密度为1.15-1.20的浓缩物;
(4)在步骤(3)的浓缩物中添加辅料,待浓缩至20℃相对密度为1.40±0.2时,即得百苓膏;所述辅料为果胶、冰糖、红糖、阿胶;所述果胶的添加量为百苓膏总重的2.5%、冰糖的添加量为百苓膏总重的15%、红糖的添加量为百苓膏总重的15%、阿胶的添加量为百苓膏总重的10%。
步骤(1)中具体为取重量份配比的百合、茯苓、莲子、桑葚、龙眼肉,加6倍量水煎煮3次,每次煎煮40分钟,过滤,合并三次滤液。
步骤(4)所制备的百苓膏水分含量52.3%,可溶性固形物含量为54.0%,无焦屑等异物,产品为棕褐色半流体,气味微甜,无焦臭异味,口感极佳,宜于服用,加入热水中搅拌即溶,呈棕黄色。
与现有技术相比本发明具有以下有益效果。
本发明改善睡眠的百苓膏,配方配伍合理,制备方法简单,充分考虑到组合物中各种药物成分的充分提取,可以使原料药充分发挥治疗作用和滋补作用,能够有效改善睡眠质量,服用方便,安全无毒副作用。
具体实施方式
以下结合具体实施例对本发明作进一步说明。
实施例1
一种百苓膏,由以下重量份配比的原料制备而成:百合1份,茯苓5份,莲子5份,桑葚3份,龙眼肉4份,缬草3份。
一种制备百苓膏的方法,包括以下步骤:
(1)选取干燥的百合、茯苓、莲子、桑葚、龙眼肉粉碎过筛,取重量份配比的百合、茯苓、莲子、桑葚、龙眼肉,加6倍量水煎煮3次,每次煎煮40分钟,过滤,合并三次滤液。
(2)取重量份配比的缬草用酒精度为35%粮酒回流提取得提取液;
(3)将步骤(1)所得的滤液和步骤(2)所得提取液合并后浓缩,浓缩至80℃时相对密度为1.15-1.20的浓缩物;
(4)在步骤(3)的浓缩物中添加辅料,待浓缩至20℃相对密度为1.40±0.2时,即得百苓膏;所述辅料为果胶、冰糖、红糖、阿胶;所述果胶的添加量为百苓膏总重的2.5%、冰糖的添加量为百苓膏总重的15%、红糖的添加量为百苓膏总重的15%、阿胶的添加量为百苓膏总重的10%。
所制备的百苓膏水分含量52.3%,可溶性固形物含量为54.0%,无焦屑等异物,产品为棕褐色半流体,气味微甜,无焦臭异味,口感极佳,宜于服用,加入热水中搅拌即溶,呈棕黄色。
实施例2
一种百苓膏,由以下重量份配比的原料制备而成:百合3份,茯苓3份,莲子5份,桑葚1份,龙眼肉5份,缬草1份。
一种制备百苓膏的方法,同实施例1
实施例3
一种百苓膏,由以下重量份配比的原料制备而成:百合2份,茯苓4份,莲子3份,桑葚2份,龙眼肉3份,缬草2份。
一种制备百苓膏的方法,同实施例1
为检验本发明改善睡眠的效果,选取120例失眠患者食用上述实施例3制得的百苓膏。其中男性50例,女性50例,年龄22-73岁,平均年龄47岁。
检验标准:
(1)以睡眠障碍为几乎惟一的症状,其他症状均继发于失眠,包括难以入睡、睡眠不深、易醒、多梦、早醒、醒后不易再睡、醒后感不适、疲乏或白天困倦。
(2)上述睡眠障碍每周至少发生三次,并持续一个月以上。
(3)失眠引起显著的苦恼,或精神活动效率下降,或妨碍社会功能。
(4)不是任何一种躯体疾病或精神障碍症状的一部分。
检验方法:食用本发明百苓膏30天,每天20g。
疗效评定标准:
(1)治愈:睡眠深度、入睡速度、睡眠时间均恢复正常者;
(2)显效:睡眠深度、入睡速度明显改善、睡眠时间增加大于2小时者;
(3)有效:睡眠深度、入睡速度有所改善、睡眠时间增加大于1小时者和原先服安眠药才入睡,食用百苓膏后可以不需服药的患者;
(4)无效:食用百苓膏后无症状改善者。
结果:实验组70例失眠患者服用本发明百苓膏30天后,治愈89例,显效12例,有效19例,无效0例。总有效率为100%。
典型病例:1、张某,女,65岁,已患失眠症状3年,伴有乏力、健忘症状。常服安定,每晚仅能入睡3小时左右,最好时睡4小时。经服用本发明百苓膏60天后,每晚能轻易入睡。
2、王某,女,32岁,患失眠症1年,每日需服安眠药入睡,经食用本发明中药组合物30天后,每晚能轻易入睡。
3、谢某,男,52岁,患失眠症1年,伴有头晕,腰酸背痛等症状,经食用本发明中药组合物30天后,每晚能轻易入睡。
本发明可用其他的不违背本发明的精神或主要特征的具体形式来概述。因此,无论从哪一点来看,本发明的上述实施方案都只能认为是对本发明的说明而不能限制发明,权利要求书指出了本发明的范围,而上述的说明并未指出本发明的范围,因此,在与本发明的权利要求书相当的含义和范围内的任何变化,都应认为是包括在权利要求书的范围内。
Claims (5)
1.一种百苓膏,其特征在于,由以下重量份配比的原料制备而成:百合1-3份,茯苓3-5份,莲子4-5份,桑葚1-3份,龙眼肉4-5份,缬草1-3份。
2.根据权利要求1所述的一种百苓膏,其特征在于,由以下重量份配比的原料制备而成:百合2份,茯苓4份,莲子3份,桑葚2份,龙眼肉3份,缬草2份。
3.一种制备如权利要求1所述的百苓膏的方法,包括以下步骤:
(1)取重量份配比的百合、茯苓、莲子、桑葚、龙眼肉加水煎煮,过滤,取滤液备用;
(2)取重量份配比的缬草用酒精度为35%粮酒回流提取得提取液;
(3)将步骤(1)所得的滤液和步骤(2)所得提取液合并后浓缩,浓缩至80℃时相对密度为1.15-1.20的浓缩物;
(4)在步骤(3)的浓缩物中添加辅料,待浓缩至20℃相对密度为1.40±0.2时,即得百苓膏;所述辅料为果胶、冰糖、红糖、阿胶;所述果胶的添加量为百苓膏总重的2.5%、冰糖的添加量为百苓膏总重的15%、红糖的添加量为百苓膏总重的15%、阿胶的添加量为百苓膏总重的10%。
4.根据权利要求3所述的一种制备百苓膏的方法,其特征在于,步骤(1)中具体为取重量份配比的百合、茯苓、莲子、桑葚、龙眼肉,加6倍量水煎煮3次,每次煎煮40分钟,过滤,合并三次滤液。
5.根据权利要求3所述的一种制备百苓膏的方法,其特征在于,步骤(4)所制备的百苓膏水分含量52.3%,可溶性固形物含量为54.0%,无焦屑异物,产品为棕褐色半流体,气味微甜,无焦臭异味,口感极佳,宜于服用,加入热水中搅拌即溶,呈棕黄色。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710941477.3A CN108567888A (zh) | 2017-10-11 | 2017-10-11 | 一种百苓膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710941477.3A CN108567888A (zh) | 2017-10-11 | 2017-10-11 | 一种百苓膏及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108567888A true CN108567888A (zh) | 2018-09-25 |
Family
ID=63576317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710941477.3A Pending CN108567888A (zh) | 2017-10-11 | 2017-10-11 | 一种百苓膏及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108567888A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110585331A (zh) * | 2019-09-09 | 2019-12-20 | 周求保 | 一种桑葚助眠膏及制备方法 |
CN113208106A (zh) * | 2021-05-11 | 2021-08-06 | 赵敏 | 一种改善熬夜疲劳的食物配方及制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101218976A (zh) * | 2007-12-30 | 2008-07-16 | 王凤越 | 一种改善睡眠的保健食品及其制备方法 |
CN104587167A (zh) * | 2015-02-11 | 2015-05-06 | 广州白云山潘高寿药业股份有限公司 | 养心安神的中药提取物及其制备方法、应用和养心安神膏 |
CN106070821A (zh) * | 2016-08-17 | 2016-11-09 | 钱灿星 | 一种莲子乌龙茶凉茶饮料及其制备方法 |
-
2017
- 2017-10-11 CN CN201710941477.3A patent/CN108567888A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101218976A (zh) * | 2007-12-30 | 2008-07-16 | 王凤越 | 一种改善睡眠的保健食品及其制备方法 |
CN104587167A (zh) * | 2015-02-11 | 2015-05-06 | 广州白云山潘高寿药业股份有限公司 | 养心安神的中药提取物及其制备方法、应用和养心安神膏 |
CN106070821A (zh) * | 2016-08-17 | 2016-11-09 | 钱灿星 | 一种莲子乌龙茶凉茶饮料及其制备方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110585331A (zh) * | 2019-09-09 | 2019-12-20 | 周求保 | 一种桑葚助眠膏及制备方法 |
CN113208106A (zh) * | 2021-05-11 | 2021-08-06 | 赵敏 | 一种改善熬夜疲劳的食物配方及制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101999647B (zh) | 功能含化阿胶系列产品及其制备方法 | |
CN103493941B (zh) | 一种减肥保健茶及其制备方法 | |
CN103461631A (zh) | 茶糖食品及其制作方法 | |
CN102824472A (zh) | 一种用于女性补气养血的药酒 | |
CN103340266A (zh) | 由植物叶与中药配制的复合保健茶 | |
CN101669624B (zh) | 一种具有改善妇女贫血功能的中药八宝茶及其制备方法 | |
CN107213451A (zh) | 改善人体微循环障碍的益生菌发酵中药制剂及其制备方法 | |
KR20130014766A (ko) | 소아비염 치료용 한약 조성물 및 이의 제조방법 | |
CN107223979A (zh) | 一种山药黄精泡腾片及其制备方法 | |
CN108567888A (zh) | 一种百苓膏及其制备方法 | |
WO2014079395A1 (zh) | 一种可以提高免疫力的油类混合物 | |
CN103393922B (zh) | 阿胶冰糖雪梨膏及其制备方法 | |
CN102258628B (zh) | 一种具有促进排铅作用的中药组合物 | |
CN106581292A (zh) | 龙族膏方及其制备方法 | |
CN103584105A (zh) | 一种止咳润肺膏及其制备方法 | |
CN106173155A (zh) | 一种石斛软糖及其制作方法 | |
CN102559460A (zh) | 一种养生酒及其制备方法 | |
CN104388263A (zh) | 山楂桂圆养生中药酒及制备方法 | |
CN103191363A (zh) | 一种治疗小儿疳积的中药组合物及其制备方法 | |
CN103584244A (zh) | 清热润肺饮料其制备方法 | |
CN103750096A (zh) | 富含植物精华的蜂胶蜜及其制备方法 | |
CN104825800B (zh) | 一种治疗失眠症的药物及其制备方法 | |
CN104383232B (zh) | 清热解毒苦丁茶含片及其生产方法 | |
CN103719484B (zh) | 一种养肝茶 | |
CN106620475A (zh) | 一种防治糖尿病认知障碍的中药组合物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180925 |